This event has ended. Visit the official site or create your own event on Sched.

IAS 2018

8:30am EDT

Complimentary Continental Breakfast TBA

9:00am EDT

Opening Remarks TBA

9:10am EDT

Advances in Basic and Clinical Immunology 2018 TBALeonard H. Calabrese, DO

9:50am EDT

Epigenetics for the Clinician - What this Means for Managing IMIDs TBAJoel Pekow, MD

10:30am EDT

Recent Advances in the Treatment of Moderate-to-Severe Psoriasis: A Focus on Targeted Agents TBAJoel M. Gelfand, MD, MSCE

11:10am EDT

Biological Agents in Rheumatology: A Virtual Reality Tour through Psoriatic Arthritis and Rheumatoid Arthritis TBA

12:10pm EDT

LUNCH Innovation Theater - Taltz: Perspectives from Dual Specialities TBAEvan Siegel, MD • Alice Gottlieb, MD, PhD

1:35pm EDT

WORKSHOPS: Select 1 of 3 Topics TBA The Treatment of Giant Cell Arteritis Current Era: IL-6 blockade and other treatment strategies TBASebastian Unizony, MD

2:15pm EDT

WORKSHOPS: Select 1 of 3 Topics TBA

2:55pm EDT

Complimentary Refreshments TBA

3:05pm EDT

Keynote Presentation - Patient Perspective: Living Life with Multiple Immune-Mediated Inflammatory Diseases TBALilly Stairs

3:55pm EDT

Grand Opening of Exhibit Hall TBA

5:10pm EDT

DINNER Innovation Theater - The Role of IL-6 in Rheumatoid Arthritis TBALeonard H. Calabrese, DO

7:15am EDT

BREAKFAST Innovation Theater - Consider Stelara® As a First-Line Biologic Treatment For Adults With Moderately To Severely Active Crohns Disease TBACharles A. Sninsky, MD

8:30am EDT

Morning Welcome TBA

8:35am EDT

Oculus Virtual Reality View: New Biologics for Improved Skin Clearance in Psoriasis TBAJoel M. Gelfand, MD, MSCE

9:35am EDT

The Dawn of Biosimilars in the Management of IMIDs: Understanding & Integrating Biosimilar Data into Informed, Collaborative Care TBAJonathan Kay, MD

10:15am EDT

Overcoming Diagnostic and Treatment Challenges in Pemphigus Vulgaris TBADonna Culton, MD, PhD

10:45am EDT

Coffee with your Colleagues in the Exhibit Hall TBA

11:20am EDT

New Advances in the Impact of Anti-Inflammatory Treatment on Cardiovascular Risk TBAJoel M. Gelfand, MD, MSCE

12:00pm EDT

LUNCH Innovation Theater - Non-infectious (NI) Uveitis The Importance of Prompt Recognition and Treatment TBAStephen Damien Anesi, MD

1:25pm EDT

WORKSHOPS: Select 1 of 3 Topics TBA

2:05pm EDT

WORKSHOPS: Select 1 of 3 Topics TBA

2:45pm EDT

Coffee with your Colleagues in the Exhibit Hall TBA

3:20pm EDT

SLE Chronic Disease Management Pathogenesis, Assessment, Targeted Biological Therapies, Prevention, and Long-term Care TBAMichelle A. Petri, MD, MPH

4:00pm EDT

IL-6 in Health and Disease TBAProf. Dr. Stefan Rose-John

4:40pm EDT

Co-Chairs Complex Clinical Case Review TBAJoseph F. Merola, MD, MMSc, FAAD, FACR • Adam S Cheifetz, MD • Mital Patel, MD

5:20pm EDT

Exhibit Hall Reception TBA

8:00am EDT

BREAKFAST Innovation Theater - Giant Cell Arteritis (GCA): Disease State Overview and Current Treatment Considerations TBALeonard H. Calabrese, DO

9:15am EDT

Morning Welcome TBA

9:20am EDT

Therapeutic Drug Monitoring of Anti-TNF TBAAdam S Cheifetz, MD

10:00am EDT

Psoriatic Arthritis: New Choices and Treatment Options TBAJoseph F. Merola, MD, MMSc, FAAD, FACR

10:40am EDT

Predicting and Preventing Serious lnfections with Biologic Therapies TBAKevin Winthrop, MD, MPH

11:20am EDT

Managing IBD with Targeted Pathophysiologic Strategies TBAStephen B. Hanauer, MD

12:05pm EDT

LUNCH Innovation Theater - Cytokine Signaling & the JAK-STAT Pathway: Role in Rheumatoid Arthritis (RA) TBATheresa Lawrence Ford, MD

1:25pm EDT

Exploring the Role of JAK-Inhibitors Across the Spectrum of IMIDs TBAVibeke Strand, MD, MACR, FACP

2:05pm EDT

Managing Pregnancy and IMIDs TBAMarla Dubinsky, MD

2:45pm EDT

Fecal Microbiota Transplantation and its Emerging Role in Immune Mediated Inflammatory Diseases TBAJessica R. Allegretti, MD, MPH

3:25pm EDT

Closing Remarks TBA